Cite
Armstrong DG, Orgill DP, Galiano R, et al. A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis. Int Wound J. 2021;doi: 10.1111/iwj.13598.
Armstrong, D. G., Orgill, D. P., Galiano, R., Glat, P. M., Didomenico, L., Reyzelman, A., Snyder, R., Li, W. W., Carter, M., & Zelen, C. M. (2021). A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis. International wound journal, . https://doi.org/10.1111/iwj.13598
Armstrong, David G, et al. "A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis." International wound journal vol. (2021). doi: https://doi.org/10.1111/iwj.13598
Armstrong DG, Orgill DP, Galiano R, Glat PM, Didomenico L, Reyzelman A, Snyder R, Li WW, Carter M, Zelen CM. A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis. Int Wound J. 2021 May 04; doi: 10.1111/iwj.13598. Epub 2021 May 04. PMID: 33942506.
Copy
Download .nbib